Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Asset Utilization Ratio: 2024

Historic Asset Utilization Ratio for Silence Therapeutics (SLN) over the last 1 years, with Dec 2024 value amounting to 0.27.

  • Silence Therapeutics' Asset Utilization Ratio was N/A to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year change of. This contributed to the annual value of 0.27 for FY2024, which is N/A change from last year.
  • Per Silence Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.27 for FY2024.
  • Over the past 5 years, Silence Therapeutics' Asset Utilization Ratio peaked at 0.27 during FY2024, and registered a low of 0.27 during FY2024.